Crossref Citations
This article has been cited by the following publications. This list is generated based on data provided by
Crossref.
1960.
ADENOVIRUS VACCINATION.
The Lancet,
Vol. 276,
Issue. 7161,
p.
1182.
1960.
THE MEDICAL ADVISER.
The Lancet,
Vol. 276,
Issue. 7161,
p.
1181.
1962.
VACCINATION AGAINST ADENOVIRUSES.
The Lancet,
Vol. 279,
Issue. 7242,
p.
1284.
1962.
THE CANCER COAGULATION FACTOR.
The Lancet,
Vol. 279,
Issue. 7242,
p.
1285.
1963.
References.
Acta Paediatrica,
Vol. 52,
Issue. S142,
p.
24.
Brandon, F.B.
and
McLean, I.Wm.
1963.
Vol. 9,
Issue. ,
p.
157.
Haagen, Eugen
1964.
Viruskrankheiten des Menschen.
p.
463.
Hilleman, M.R.
1965.
Immunologic, chemotherapeutic and interferon approaches to control of viral disease.
The American Journal of Medicine,
Vol. 38,
Issue. 5,
p.
751.
Germer, W. D.
1965.
Handbuch der Schutzimpfungen.
p.
606.
NORRBY, ERLING
1971.
Comparative Virology.
p.
105.
Gaydos, Charlotte A.
and
Gray, Gregory C.
2008.
Vaccines.
p.
1103.
Xie, Li
Yu, Xin-Fen
Sun, Zhou
Yang, Xu-Hui
Huang, Ren-Jie
Wang, Jing
Yu, Apeng
Zheng, Lin
Yu, Man-Chu
Hu, Xiao-Wei
Wang, Ban-Ma
Chen, Jin
Pan, Jing-Cao
and
Liu, She-Lan
2012.
Two Adenovirus Serotype 3 Outbreaks Associated with Febrile Respiratory Disease and Pharyngoconjunctival Fever in Children under 15 Years of Age in Hangzhou, China, during 2011.
Journal of Clinical Microbiology,
Vol. 50,
Issue. 6,
p.
1879.
Gray, Gregory C.
2013.
Vaccines.
p.
113.
TEUNIS, P.
SCHIJVEN, J.
and
RUTJES, S.
2016.
A generalized dose-response relationship for adenovirus infection and illness by exposure pathway.
Epidemiology and Infection,
Vol. 144,
Issue. 16,
p.
3461.
Gray, Gregory C.
and
Erdman, Dean D.
2018.
Plotkin's Vaccines.
p.
121.
Arav, Yehuda
Fattal, Eyal
and
Klausner, Ziv
2022.
Is the Increased Transmissibility of SARS-CoV-2 Variants Driven by within or Outside-Host Processes?.
Mathematics,
Vol. 10,
Issue. 19,
p.
3422.
Gray, Gregory C.
and
Erdman, Dean D.
2023.
Plotkin's Vaccines.
p.
145.